Low-frequency variants in TREM2 have been reported to increase AD risk by almost 3–4 times, and, therefore, investigating the functional roles of such variants may be crucial to understanding the involvement of TREM2 in various neurodegenerative diseases [26]. Here, TREM2 is linked to neurodegenerative disease.